BecauseNSAIDs possess COX-2-inhibitory activity and are commonly used by many peopleincluding cancer patients, caution should be taken during cancer chemotherapyto avoid potentially diminished therapeutic efficacy due to COX-2 inhibition. Here, PTGS2 is linked to cancer.